BLASENKARZINOM-BIOMARKER
European patent · EP3066474 · In force
Register entry
- Publication number
- EP3066474
- Application number
- EP14860176
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 5, 2014
- Published
- Sep 14, 2016
- Granted
- Apr 3, 2019
- Protection ends at the latest
- Nov 4, 2034
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C12Q 1/6886 (2018.01)G01N 33/574 (2006.01)
- Priority
- SG 201308203 05.11.2013
- PCT application
- PCT/SG2014/000521 05.11.2014
- PCT publication
- WO2015/069187 14.05.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Dec 1, 2022
Change
Published in Swissreg on 01.12.2022
- Apr 9, 2019
Agent entered
- Representative
- Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich
Published in Swissreg on 09.04.2019
- Apr 3, 2019
Granted
Published in Swissreg on 03.04.2019
Parties
Holder
Agent
Inventor
KUMAR, Prashant
Singapore 138673, SG
THIERY, Jean Paul
Singapore 138673, SG
GUNARATNE, Jayantha
Singapore 138673, SG
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.